Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Esperion Therapeutics, Inc. (ESPR)

« Back to company index

ESPR Chatter Timeline

Stock Ticker for ESPR

Most Active Tweeters for ESPR

UserTweets
@Tickeron 14
@ZolmaxNews 4
@Gambiste1 4
@WatchlistN 4
@OlympiaReport 4

Recent Tweets for ESPR

OlympiaReport @OlympiaReport
Esperion Therapeutics $ESPR Trading Up 9.8% https://t.co/jaYuTZbKXL
April 2nd 2020, 7:04pm
tradersreport @tradersreport
RT @Tickeron: $ESPR's 10-day Moving Average crossed below its 50-day Moving Average on March 3, 2020. View odds for this and other indicato…
April 2nd 2020, 6:04pm
Tickeron @Tickeron
$ESPR's 10-day Moving Average crossed below its 50-day Moving Average on March 3, 2020. View odds for this and othe… https://t.co/me8CHGR3li
April 2nd 2020, 6:04pm
ThisLincolnian @ThisLincolnian
-$3.23 Earnings Per Share Expected for Esperion Therapeutics Inc $ESPR This Quarter https://t.co/nCUzagMKgw
April 2nd 2020, 5:04am
ZolmaxNews @ZolmaxNews
Analysts Expect Esperion Therapeutics Inc $ESPR to Announce -$3.23 Earnings Per Share https://t.co/2Dh5qjuCKH
April 2nd 2020, 5:04am
WatchlistN @WatchlistN
Analysts Expect Esperion Therapeutics Inc $ESPR to Announce -$3.23 Earnings Per Share https://t.co/TPcyHaFWdj
April 2nd 2020, 5:04am
AmericanBanking @AmericanBanking
Analysts Expect Esperion Therapeutics Inc $ESPR to Announce -$3.23 Earnings Per Share https://t.co/ebxVg4AtyZ #stocks
April 2nd 2020, 5:04am
Tickeron @Tickeron
$ESPR's 10-day Moving Average moved below its 50-day Moving Average on March 3, 2020. View odds for this and other… https://t.co/XpGyLVWVjV
April 1st 2020, 8:04pm
AmericanBanking @AmericanBanking
Needham & Company LLC Reaffirms Buy Rating for Esperion Therapeutics $ESPR https://t.co/5mZi5w5Soi #stocks
April 1st 2020, 7:04pm
Gambiste1 @Gambiste1
RT @portefeuillefun: Bought 0.65k $ESPR at $30.04, now 0.8k #vssporte shares.
April 1st 2020, 6:04pm
portefeuillefun @portefeuillefun
Bought 0.65k $ESPR at $30.04, now 0.8k #vssporte shares.
April 1st 2020, 5:04pm
OlympiaReport @OlympiaReport
Esperion Therapeutics $ESPR Receives Buy Rating from Needham & Company LLC https://t.co/wIHgWEaics
April 1st 2020, 5:04pm
timfris @timfris
RT @_Zenil_: Sell the company $espr
April 1st 2020, 1:04pm
tradingbotnyse @tradingbotnyse
Stocks with greater movement, last 15 minutes $ESPR +/- 2.66% Esperion Therapeutics Inc. $ET +/- 2.56% Energy Tran… https://t.co/h6uQICHvXl
April 1st 2020, 11:04am
AmericanBanking @AmericanBanking
Esperion Therapeutics $ESPR Earns Buy Rating from Analysts at Bank of America https://t.co/IAvrJ4JCGE #stocks
April 1st 2020, 9:04am
dakotafinancial @dakotafinancial
Esperion Therapeutics $ESPR Earns Buy Rating from Analysts at Bank of America https://t.co/pPqSwD6Dic
April 1st 2020, 9:04am
ConsumerFeed @ConsumerFeed
Esperion Therapeutics $ESPR Earns Buy Rating from Analysts at Bank of America https://t.co/h2HDd1nbSQ
April 1st 2020, 9:04am
TranscriptDaily @TranscriptDaily
Esperion Therapeutics $ESPR Earns Buy Rating from Analysts at Bank of America https://t.co/bxRoYGkhfl
April 1st 2020, 9:04am
Gambiste1 @Gambiste1
RT @odibro: $ESPR initiated with a Buy at BofA. $50 PT
April 1st 2020, 6:04am
FireTrader05 @FireTrader05
$ESPR BofA analyst Geoff Meachem initiated coverage of Esperion with a Buy rating and $50 price target
April 1st 2020, 6:04am
Gambiste1 @Gambiste1
RT @RNAiAnalyst: @semodough Probably 1 of the least important products to launch. And with #COVID19...forget about it. $ESPR
April 1st 2020, 6:04am
Gambiste1 @Gambiste1
RT @semodough: Baml $ESPR US: Esperion Therapeutics: Reinstatement of Coverage - Highly awaited launch to re-engage investors despite macro…
April 1st 2020, 6:04am
odibro @odibro
$ESPR initiated with a Buy at BofA. $50 PT
April 1st 2020, 6:04am
RNAiAnalyst @RNAiAnalyst
@semodough Probably 1 of the least important products to launch. And with #COVID19...forget about it. $ESPR
April 1st 2020, 6:04am
semodough @semodough
Baml $ESPR US: Esperion Therapeutics: Reinstatement of Coverage - Highly awaited launch to re-engage investors desp… https://t.co/9xukJZ27sO
April 1st 2020, 6:04am
WatchlistN @WatchlistN
Esperion Therapeutics $ESPR Given “Buy” Rating at Needham & Company LLC https://t.co/2bwueXTSoz
April 1st 2020, 3:04am
Tickeron @Tickeron
$ESPR's 10-day Moving Average broke below its 50-day Moving Average on March 3, 2020. View odds for this and other… https://t.co/VME2bcbxLV
March 31st 2020, 6:03pm
AniuStudent @AniuStudent
Actually, my point is, at least 4 confused Twitter investors (aka so many), $ESPR just lost a competitor. & b4 the… https://t.co/EcmLGW2Sgw
March 31st 2020, 10:03am
_Zenil_ @_Zenil_
Sell the company $espr
March 31st 2020, 10:03am
WatchlistN @WatchlistN
Esperion Therapeutics $ESPR Downgraded by BidaskClub https://t.co/4HKJFg9tZy
March 31st 2020, 6:03am
poorcoach44 @poorcoach44
RT @EsperionInc: $ESPR announces commercial availability of the NEXLETOL™ (bempedoic acid) tablet and pledges a conscientious launch during…
March 30th 2020, 10:03pm
Briefingcom @Briefingcom
$ESPR: Esperion Therapeutics announces availability of NEXLETOL https://t.co/dMvPOvJcCU
March 30th 2020, 6:03pm
Tickeron @Tickeron
$ESPR enters an Uptrend because Momentum Indicator exceeded the 0 level on March 26, 2020. View odds for this and o… https://t.co/4U746Yzn6M
March 30th 2020, 4:03pm
EsperionInc @EsperionInc
$ESPR announces commercial availability of the NEXLETOL™ (bempedoic acid) tablet and pledges a conscientious launch… https://t.co/ffmu4QTQfd
March 30th 2020, 4:03pm
otcdynamics @otcdynamics
$ESPR Esperion Announces Commercial Availability of the NEXLETOL™ (bempedoic acid) Tablet and Pledges a C https://t.co/ilGa3abPpn
March 30th 2020, 4:03pm
timfris @timfris
@arenella1 @semodough $ESPR has been taking an absolute beating too.
March 30th 2020, 3:03pm
MLind_Benco @MLind_Benco
RT @AniuStudent: $ESPR is a cheap, oral pill, known to reduce inflammation, & LDL at a reduced level compared to #PCSK9 injectables-either…
March 30th 2020, 11:03am
MLind_Benco @MLind_Benco
$ESPR cholesterol pill that is less expensive, effective, safe and good for patients who cannot tolerate statin dru… https://t.co/yu86pCu73J
March 30th 2020, 11:03am
dailypoliticaln @dailypoliticaln
Esperion Therapeutics $ESPR Lifted to “Buy” at Zacks Investment Research https://t.co/SfWfWOGB2V
March 30th 2020, 6:03am
dailypoliticaln @dailypoliticaln
Esperion Therapeutics $ESPR Raised to Buy at Zacks Investment Research https://t.co/U0ORUIfdOM
March 30th 2020, 6:03am
stocknewstimes @stocknewstimes
Esperion Therapeutics $ESPR Raised to Buy at Zacks Investment Research https://t.co/gPuZIgCmMQ
March 30th 2020, 5:03am
dakotafinancial @dakotafinancial
Esperion Therapeutics $ESPR Lifted to “Buy” at Zacks Investment Research https://t.co/EuUuZpfgzW
March 30th 2020, 5:03am
ZolmaxNews @ZolmaxNews
Esperion Therapeutics $ESPR Lifted to “Buy” at Zacks Investment Research https://t.co/wZfJJ9bKPl
March 30th 2020, 5:03am
ConsumerFeed @ConsumerFeed
Esperion Therapeutics $ESPR Lifted to “Buy” at Zacks Investment Research https://t.co/KSl1Loytwj
March 30th 2020, 5:03am
Tickeron @Tickeron
$ESPR enters an Uptrend because Momentum Indicator exceeded the 0 level on March 26, 2020. View odds for this and o… https://t.co/vHzjUSuAqV
March 29th 2020, 5:03pm
HealthcareBeat @HealthcareBeat
Man Group Grows Stake in Esperion Therapeutics Inc $ESPR https://t.co/qiEX4Cbcmm
March 29th 2020, 3:03pm
gcassidy718 @gcassidy718
$ESPR major stock movement -5.62 % change recently https://t.co/ZJ7rwkXcgV
March 29th 2020, 3:03pm
BlueBioNow @BlueBioNow
$ESPR price movement -5.62 % https://t.co/ZFif3yGLgm
March 28th 2020, 8:03pm
Tickeron @Tickeron
$ESPR enters an Uptrend because Momentum Indicator exceeded the 0 level on March 26, 2020. View odds for this and o… https://t.co/d03QdN2Mgc
March 28th 2020, 5:03pm
stevedoc22 @stevedoc22
Question: is $ESPR still planning to launch Nexletol during a pandemic lockdown? Should we have concerns about this… https://t.co/y5MG8sXDzP
March 28th 2020, 2:03pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.